New molecular entity: FDA approved icosapent ethyl (Vascepa, Amarin Pharmaceuticals Ireland Limited), an ethyl ester of eicosapentaenoic acid (EPA), as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Vascepa (Icosapent ethyl)

Newsletter